ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,03025
-0,01%
Bitcoin
103.000,00
-1,08%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) News

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TNXP
DatumZeitQuelleÜberschriftSymbolFirma
08/01/202513h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
08/01/202513h00GlobeNewswire Inc.Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market AccessNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/01/202513h00GlobeNewswire Inc.Tonix Pharmaceuticals to Present at Two Upcoming January Investor ConferencesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/01/202520h56Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
23/12/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
23/12/202414h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
20/12/202422h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
20/12/202422h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
17/12/202415h25AllPennyStocks.comThis Micro Cap Is Getting Bid Up Prior To Opening BellNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
17/12/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
17/12/202414h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/12/202422h13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/12/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/12/202413h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic HiresNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
26/11/202413h00GlobeNewswire Inc.Tonix Pharmaceuticals to Participate in the NobleCon20 Investor ConferenceNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
18/11/202422h05GlobeNewswire Inc.Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit VirtualNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
18/11/202413h00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
14/11/202422h42Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
14/11/202422h40Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/11/202422h05GlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/11/202415h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/11/202415h05GlobeNewswire Inc.Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised AnimalsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/11/202423h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/11/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/11/202414h00GlobeNewswire Inc.Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
08/11/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
04/11/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
04/11/202413h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in KenyaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
01/11/202412h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
01/11/202412h00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:TNXP

Kürzlich von Ihnen besucht

BIBX
BNFUSDT
BonFi
DOWI
DJTLQUT
DJ US Thematic Long Qual...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten